These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 21493592)
1. Histone methyltransferase KMT1A restrains entry of alveolar rhabdomyosarcoma cells into a myogenic differentiated state. Lee MH; Jothi M; Gudkov AV; Mal AK Cancer Res; 2011 Jun; 71(11):3921-31. PubMed ID: 21493592 [TBL] [Abstract][Full Text] [Related]
2. p38α MAPK disables KMT1A-mediated repression of myogenic differentiation program. Chatterjee B; Wolff DW; Jothi M; Mal M; Mal AK Skelet Muscle; 2016; 6():28. PubMed ID: 27551368 [TBL] [Abstract][Full Text] [Related]
3. Camptothecin exhibits topoisomerase1-independent KMT1A suppression and myogenic differentiation in alveolar rhabdomyosarcoma cells. Wolff DW; Lee MH; Jothi M; Mal M; Li F; Mal AK Oncotarget; 2018 May; 9(40):25796-25807. PubMed ID: 29899822 [TBL] [Abstract][Full Text] [Related]
4. SNAIL is a key regulator of alveolar rhabdomyosarcoma tumor growth and differentiation through repression of MYF5 and MYOD function. Skrzypek K; Kusienicka A; Trzyna E; Szewczyk B; Ulman A; Konieczny P; Adamus T; Badyra B; Kortylewski M; Majka M Cell Death Dis; 2018 May; 9(6):643. PubMed ID: 29844345 [TBL] [Abstract][Full Text] [Related]
8. SMYD1 and G6PD modulation are critical events for miR-206-mediated differentiation of rhabdomyosarcoma. Coda DM; Lingua MF; Morena D; Foglizzo V; Bersani F; Ala U; Ponzetto C; Taulli R Cell Cycle; 2015; 14(9):1389-402. PubMed ID: 25644430 [TBL] [Abstract][Full Text] [Related]
9. p38-{gamma}-dependent gene silencing restricts entry into the myogenic differentiation program. Gillespie MA; Le Grand F; Scimè A; Kuang S; von Maltzahn J; Seale V; Cuenda A; Ranish JA; Rudnicki MA J Cell Biol; 2009 Dec; 187(7):991-1005. PubMed ID: 20026657 [TBL] [Abstract][Full Text] [Related]
10. The Wnt-pathway corepressor TLE3 interacts with the histone methyltransferase KMT1A to inhibit differentiation in Rhabdomyosarcoma. Kalita B; Sahu S; Bharadwaj A; Panneerselvam L; Martinez-Cebrian G; Agarwal M; Mathew SJ Oncogene; 2024 Feb; 43(7):524-538. PubMed ID: 38177411 [TBL] [Abstract][Full Text] [Related]
11. AKT and PAX3-FKHR cooperation enforces myogenic differentiation blockade in alveolar rhabdomyosarcoma cell. Jothi M; Nishijo K; Keller C; Mal AK Cell Cycle; 2012 Mar; 11(5):895-908. PubMed ID: 22333587 [TBL] [Abstract][Full Text] [Related]
12. The p38 MAPK family, a pushmi-pullyu of skeletal muscle differentiation. Lassar AB J Cell Biol; 2009 Dec; 187(7):941-3. PubMed ID: 20026653 [TBL] [Abstract][Full Text] [Related]
13. Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative Rhabdomyosarcoma. Pomella S; Sreenivas P; Gryder BE; Wang L; Milewski D; Cassandri M; Baxi K; Hensch NR; Carcarino E; Song Y; Chou HC; Yohe ME; Stanton BZ; Amadio B; Caruana I; De Stefanis C; De Vito R; Locatelli F; Chen Y; Chen EY; Houghton P; Khan J; Rota R; Ignatius MS Nat Commun; 2021 Jan; 12(1):192. PubMed ID: 33420019 [TBL] [Abstract][Full Text] [Related]
14. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells. Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709 [TBL] [Abstract][Full Text] [Related]
15. Tip60 regulates myoblast differentiation by enhancing the transcriptional activity of MyoD via their physical interactions. Kim JW; Jang SM; Kim CH; An JH; Kang EJ; Choi KH FEBS J; 2011 Nov; 278(22):4394-404. PubMed ID: 21936881 [TBL] [Abstract][Full Text] [Related]
16. DNMT3B in vitro knocking-down is able to reverse embryonal rhabdomyosarcoma cell phenotype through inhibition of proliferation and induction of myogenic differentiation. Megiorni F; Camero S; Ceccarelli S; McDowell HP; Mannarino O; Marampon F; Pizer B; Shukla R; Pizzuti A; Marchese C; Clerico A; Dominici C Oncotarget; 2016 Nov; 7(48):79342-79356. PubMed ID: 27764816 [TBL] [Abstract][Full Text] [Related]
17. The histone demethylase KDM4B interacts with MyoD to regulate myogenic differentiation in C2C12 myoblast cells. Choi JH; Song YJ; Lee H Biochem Biophys Res Commun; 2015 Jan; 456(4):872-8. PubMed ID: 25534856 [TBL] [Abstract][Full Text] [Related]
18. A human Myogenin promoter modified to be highly active in alveolar rhabdomyosarcoma drives an effective suicide gene therapy. Pruller J; Hofer I; Ganassi M; Heher P; Ma MT; Zammit PS Cancer Gene Ther; 2021 May; 28(5):427-441. PubMed ID: 32973362 [TBL] [Abstract][Full Text] [Related]
19. Stuck in a balancing act: histone methyltransferase activity of KMT1A traps alveolar rhabdomyosarcomas in an undifferentiated state. MacQuarrie KL; Tapscott SJ Cell Cycle; 2011 Oct; 10(19):3225-6. PubMed ID: 21941084 [No Abstract] [Full Text] [Related]